Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway

被引:72
作者
Battcock, SA [1 ]
Collier, TW [1 ]
Zu, D [1 ]
Hirasawa, K [1 ]
机构
[1] Mem Univ Newfoundland, Fac Med, Div Basic Med Sci, St John, NF A1B 3V6, Canada
关键词
D O I
10.1128/JVI.80.9.4422-4430.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Interferon (IFN) is one of the molecules released by virus-infected cells, resulting in the establishment of an antiviral state within infected and neighboring cells. IFN-induced antiviral response may be subject to modulation by the cellular signaling environment of host cells which impact the effectiveness of viral replication. Here, we show that cells with an activated Ras/Raf/MEK signaling cascade allow propagation of viruses in the presence of IFN. Ras-transformed (RasV12) and vector control NIH 3T3 cells were infected with vesicular stomatitis virus (VSV) or an IFN-sensitive vaccinia virus (deIE3L) in the presence of alpha interferon. While IFN protected vector control cells from infection by both viruses, RasV12 cells were susceptible to viral infection regardless of the presence of IFN. IFN sensitivity was restored in RasV12 cells upon RNA interference (RNAi) knockdown of Ras. We further investigated which elements downstream of Ras are responsible for counteracting IFN-induced antiviral responses. A Ras effector domain mutant that can only stimulate the Raf kinase family of effectors was able to suppress the IFN response and allow VSV replication. IFN-induced antiviral mechanisms were also restored in RasV12 cells by treatment with a MEK inhibitor (IJ0126 or PD98059). Moreover, by using RNAi to MEK1 and MEK2, we determined that MEK2, rather than MEK1, is responsible for suppression of the IFN response. In conclusion, our results suggest that activation of the Ras/Raf/MEK pathway downregulates IFN-induced antiviral response.
引用
收藏
页码:4422 / 4430
页数:9
相关论文
共 67 条
[1]   Raf promotes human herpesvirus-8 (HHV-8/KSHV) infection [J].
Akula, SM ;
Ford, PW ;
Whitman, AG ;
Hamden, KE ;
Shelton, JG ;
McCubrey, JA .
ONCOGENE, 2004, 23 (30) :5227-5241
[2]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[3]   Defective translational control facilitates vesicular stomatitis virus oncolysis [J].
Balachandran, S ;
Barber, GN .
CANCER CELL, 2004, 5 (01) :51-65
[4]   Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the induction of apoptosis [J].
Balachandran, S ;
Porosnicu, M ;
Barber, GN .
JOURNAL OF VIROLOGY, 2001, 75 (07) :3474-3479
[5]   Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection [J].
Balachandran, S ;
Roberts, PC ;
Brown, LE ;
Truong, H ;
Pattnaik, AK ;
Archer, DR ;
Barber, GN .
IMMUNITY, 2000, 13 (01) :129-141
[6]   Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology [J].
Barber, SA ;
Bruett, L ;
Douglass, BR ;
Herbst, DS ;
Zink, MC ;
Clements, JE .
JOURNAL OF VIROLOGY, 2002, 76 (02) :817-828
[7]   REVERSAL OF THE INTERFERON-SENSITIVE PHENOTYPE OF A VACCINIA VIRUS LACKING E3L BY EXPRESSION OF THE REOVIRUS S4 GENE [J].
BEATTIE, E ;
DENZLER, KL ;
TARTAGLIA, J ;
PERKUS, ME ;
PAOLETTI, E ;
JACOBS, BL .
JOURNAL OF VIROLOGY, 1995, 69 (01) :499-505
[8]   Mek2 is dispensable for mouse growth and development [J].
Bélanger, LF ;
Roy, S ;
Tremblay, M ;
Brott, B ;
Steff, AM ;
Mourad, W ;
Hugo, P ;
Erikson, R ;
Charron, J .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (14) :4778-4787
[9]  
Bergmann M, 2001, CANCER RES, V61, P8188
[10]   Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model [J].
Brandt, TA ;
Jacobs, BL .
JOURNAL OF VIROLOGY, 2001, 75 (02) :850-856